Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population
Fredrik Åberg, Jaana Helenius‐Hietala, Pauli Puukka, et al.
Hepatology (2017) Vol. 67, Iss. 6, pp. 2141-2149
Closed Access | Times Cited: 220

Showing 1-25 of 220 citing articles:

Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Emelia J. Benjamin, Paul Muntner, Álvaro Alonso, et al.
Circulation (2019) Vol. 139, Iss. 10
Open Access | Times Cited: 7948
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Salim S. Virani, Álvaro Alonso, Emelia J. Benjamin, et al.
Circulation (2020) Vol. 141, Iss. 9
Open Access | Times Cited: 7687
Heart Disease and Stroke Statistics—2021 Update
Salim S. Virani, Álvaro Alonso, Hugo J. Aparicio, et al.
Circulation (2021) Vol. 143, Iss. 8
Open Access | Times Cited: 4671
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Connie W. Tsao, Aaron W. Aday, Zaid Almarzooq, et al.
Circulation (2022) Vol. 145, Iss. 8
Open Access | Times Cited: 4189
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Connie W. Tsao, Aaron W. Aday, Zaid Almarzooq, et al.
Circulation (2023) Vol. 147, Iss. 8
Open Access | Times Cited: 4073
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease
Mohammed Eslam, Arun J. Sanyal, Jacob George, et al.
Gastroenterology (2020) Vol. 158, Iss. 7, pp. 1999-2014.e1
Open Access | Times Cited: 2561
Global burden of liver disease: 2023 update
Harshad Devarbhavi, Sumeet K. Asrani, Juan Pablo Arab, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 516-537
Open Access | Times Cited: 806
2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
Seth S. Martin, Aaron W. Aday, Zaid Almarzooq, et al.
Circulation (2024) Vol. 149, Iss. 8
Open Access | Times Cited: 782
Diagnosis and Treatment of Alcohol‐Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases
David W. Crabb, Gene Y. Im, Gyöngyi Szabó, et al.
Hepatology (2019) Vol. 71, Iss. 1, pp. 306-333
Open Access | Times Cited: 674
Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation
Zobair M. Younossi, Giulio Marchesini, Helena Pinto-Cortez, et al.
Transplantation (2018) Vol. 103, Iss. 1, pp. 22-27
Open Access | Times Cited: 352
What's in a name? Renaming ‘NAFLD’ to ‘MAFLD’
Yasser Fouad, Imam Waked, Steven Bollipo, et al.
Liver International (2020) Vol. 40, Iss. 6, pp. 1254-1261
Open Access | Times Cited: 268
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
Frank Tacke, Paul Horn, Vincent Wai‐Sun Wong, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 3, pp. 492-542
Closed Access | Times Cited: 254
Fibrosis and alcohol-related liver disease
Carolin Lackner, Dina Tiniakos
Journal of Hepatology (2019) Vol. 70, Iss. 2, pp. 294-304
Open Access | Times Cited: 231
Alcohol Use in Patients with Chronic Liver Disease
Daniel Fuster, Jeffrey H. Samet
New England Journal of Medicine (2018) Vol. 379, Iss. 13, pp. 1251-1261
Closed Access | Times Cited: 181
Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Adults
Jiaye Liu, Ibrahim Ayada, Xiaofang Zhang, et al.
Clinical Gastroenterology and Hepatology (2021) Vol. 20, Iss. 3, pp. e573-e582
Open Access | Times Cited: 153
Alcohol consumption and metabolic syndrome: Clinical and epidemiological impact on liver disease
Fredrik Åberg, Christopher D. Byrne, Carlos J. Pirola, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 1, pp. 191-206
Open Access | Times Cited: 143
Clinical impact of sexual dimorphism in non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic steatohepatitis (NASH)
Patrizia Burra, Debora Bizzaro, Anna Gonta, et al.
Liver International (2021) Vol. 41, Iss. 8, pp. 1713-1733
Open Access | Times Cited: 113
Breakthroughs in therapies for NASH and remaining challenges
Vlad Ratziu, Sven Francque, Arun J. Sanyal
Journal of Hepatology (2022) Vol. 76, Iss. 6, pp. 1263-1278
Open Access | Times Cited: 104
Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives
Szu-Yi Liu, I‐Ting Tsai, Yin-Chou Hsu
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5170-5170
Open Access | Times Cited: 102
Cigarette smoking and liver diseases
David Martí‐Aguado, Ana Clemente, Ramón Bataller
Journal of Hepatology (2022) Vol. 77, Iss. 1, pp. 191-205
Open Access | Times Cited: 101
The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease
Luis Antonio Díaz, Juan Pablo Arab, Alexandre Louvet, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 12, pp. 764-783
Closed Access | Times Cited: 92
Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study
Joon Ho Moon, Seogsong Jeong, Heejoon Jang, et al.
EClinicalMedicine (2023) Vol. 65, pp. 102292-102292
Open Access | Times Cited: 73
Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis
Daniel Q. Huang, Nabil Noureddin, Veeral Ajmera, et al.
˜The œLancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 9, pp. 829-836
Open Access | Times Cited: 69
Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity
Gi‐Ae Kim, Joon Ho Moon, Won Kim
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 4, pp. 831-843
Open Access | Times Cited: 62
ACG Clinical Guideline: Alcohol-Associated Liver Disease
Loretta Jophlin, Ashwani K. Singal, Ramón Bataller, et al.
The American Journal of Gastroenterology (2023) Vol. 119, Iss. 1, pp. 30-54
Open Access | Times Cited: 58
Page 1 - Next Page

Scroll to top